dc.contributor.author
Darbà, Josep
dc.contributor.author
Marsà, Alícia
dc.date.issued
2022-10-24T12:09:20Z
dc.date.issued
2023-10-01T05:10:24Z
dc.date.issued
2022-10-01
dc.date.issued
2022-10-24T12:09:21Z
dc.identifier
https://hdl.handle.net/2445/190125
dc.description.abstract
Ischemic heart disease (IHD) is the leading global cause of death and is assumed to entail a significant social and economic burden globally. This study aimed to evaluate incidence and mortality trends of IHD in Spain and to estimate direct medical costs (...)
dc.format
application/pdf
dc.publisher
Informa Healthcare
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1080/14737167.2022.2108794
dc.relation
Expert Review of Pharmacoeconomics & Outcomes Research, 2022, vol. 22, num. 7, p. 1147-1152
dc.relation
https://doi.org/10.1080/14737167.2022.2108794
dc.rights
(c) Informa Healthcare, 2022
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Economia)
dc.subject
Política sanitària
dc.subject
Cost de l'assistència sanitària
dc.subject
Malalties cardiovasculars
dc.subject
Medical policy
dc.subject
Cost of medical care
dc.subject
Cardiovascular diseases
dc.title
Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion
